The present invention relates to an intravascular medical system. In particular, the present invention is directed to an improved balloon guide catheter with positive venting of residual air trapped therein while being prepped by the physician or interventionalist prior to being introduced into the body.
Catheters are widely used today in connection with a variety of intravascular medical procedures or treatments. One such widely adopted use or application of an intravascular catheter is in a thrombectomy medical procedure following an acute ischemic stroke (AIS) in which a sheath guide catheter (non-balloon guide catheter) or balloon guide catheter is introduced into the internal carotid artery to serve as a conduit for ancillary devices such as guidewire(s), microcatheter(s), stentriever(s) or intermediate catheter(s). The sheath guide catheter (non-balloon guide catheter) maintains access to the intended treatment location within a blood vessel and shortens procedural times by facilitating multiple passes with ancillary devices to the treatment location. Use of a balloon guide catheter provides the additional benefit, once inflated to an expanded state, of arresting blood flow and achieving complete apposition of the vessel. The blood flow arrest offers extra security in limiting the blood pressure exerted on the clot as well as maximizing the suction performance during aspiration stage, as the stentriever and/or direct aspiration catheter retracts back into the balloon guide catheter with the captured clot. While such benefits are readily apparent and clinically proven, use of a balloon guide catheter requires somewhat arduous prepping steps be followed in ridding the inflating lumen of residual air to be replaced with inflating medium both in the inflating lumen and the balloon. These prepping steps performed prior to the introduction of the balloon guide catheter into the body deter some physicians or interventionalists from using a balloon guide catheter altogether despite such advantages, instead choosing to employ a sheath guide catheter (non-balloon guide catheter) that doesn't require such prepping steps.
Prior to being introduced into the target vessel of the body, a conventional balloon guide catheter is prepped by the physician or interventionalist following a multi-step process to properly purge residual air trapped therein. This preparatory procedure typically calls for applying a vacuum or negative pressure at an inflation port to remove the residual air, followed immediately thereafter by dispensing of an inflation medium back into the catheter. This inflation lumen vacuum procedure may be required to be repeated multiple times to insure complete expulsion of the residual air. If the purging steps are not followed correctly or skipped over entirely, the residual air in the balloon guide catheter may be exhausted into the blood vessel, in the event of a balloon failure, having a dangerous and harmful effect on the patient.
It is therefore desirable to streamline the number of steps or actions to purge residual air from the balloon guide catheter increasing its desirability and ease of use while optimizing time efficiency as well reducing the potential for human error.
An aspect of the present invention is directed to an improved balloon guide catheter that minimizes the number of prepping steps or actions to rid the device of residual air.
Another aspect of the present invention relates to an improved balloon guide catheter with positive venting and method for use of such inventive catheter.
Yet another aspect of the present invention is directed to an improved balloon guide catheter in which the location of the exhaust and inflating vents ensures that inflation of the balloon with inflating medium occur only upon full and complete bleeding of the residual air from the inflating lumen.
Still another aspect of the present invention relates to an improved guide catheter in which the inflating medium serves a dual function or purpose, initially to purge the residual air from the inflating lumen and, once bled, thereafter to inflate the balloon.
While yet another aspect of the present invention is directed to an improved balloon guide catheter that when prepped by the physician or interventionalist is visibly verifiable that the balloon has been properly purged of residual air prior to introduction into the patient.
It is yet another aspect of the present invention to provide an improved balloon guide catheter with positive venting in which residual air is purged prior to introduction into the body, thereby eliminating the need for a vacuum or negative pressure during prepping.
An aspect of the present invention is directed to a balloon guide catheter including a catheter shaft having an outer surface, a proximal end, and an opposite distal end. The catheter shaft has a main lumen defined therein extending axially therethrough from the proximal end to the distal end. The main shaft is configured to receive a guidewire therein; the catheter shaft having an inflation lumen defined axially therein arranged semi-encircling the main lumen; the inflation lumen having an inlet port defined radially outward from the catheter shaft and at least one exhaust vent disposed proximate the distal end of the catheter shaft, wherein the at least one exhaust vent being disposed longitudinally through a distal terminating end of the inflation lumen or radially inward in fluid communication with the main lumen. The catheter further includes a porous membrane disposed at the at least one exhaust vent, wherein the porous membrane having a plurality of holes defined therein sized to permit only gas to pass therethrough. In addition, the catheter also has an expandable balloon secured about the outer surface of the catheter shaft proximate the distal end of the catheter shaft and coinciding with the inlet port.
Another aspect of the present invention relates to a method for using a balloon guide catheter, as described in the preceding paragraph. The method includes the step of prior to introduction of the balloon guide catheter into a target vessel, prepping the balloon guide catheter by positively venting residual air distally from the inflation lumen and the expandable balloon via the at least one exhaust vent.
A still further aspect of the present invention is directed to a method of manufacture of a positive distal vented balloon guide catheter. The method including the steps of forming a tubular main liner to form a main lumen axially therethrough; the formed tubular main liner having an etched region and a polymeric strike layer at selected surfaces. A first opening is punched radially through the formed tubular main liner that serves as a radial exhaust vent in fluid communication with the main lumen defined axially therethrough. A provided microporous membrane etched and having a polymeric strike layer at selected sections of both surfaces of the microporous membrane is positioned to cover the punched exhaust vent defined in the formed tubular main liner. The formed tubular main liner is laminated to attached together with the microporous membrane under an application of heat. Thereafter, a polymer jacket is positioned over the laminated assembly including the mandrel, the formed tubular main liner, and the microporous membrane; and heat shrink is applied to cause reflow of the polymer jacket bonding the polymer jacket to the etched/strike layer of the microporous membrane as well as to the etched/strike layer of the formed tubular main liner. In a similar fashion a tubular inflation liner is formed having an inflation lumen axially therethrough; the formed tubular inflation liner having an etched region and a polymeric strike layer at selected surfaces. A second opening s punched radially through the formed tubular inflation liner that serves as a radial exhaust vent in fluid communication with the inflation lumen defined axially therethrough. The second opening of the formed tubular inflation liner is positioned longitudinally relative to the first opening of the formed tubular main liner. At least one jacket is applied about the formed tubular inflation liner. Heat shrink is then applied to cause reflow of the at least one outer jacket forming a fused assembly to the braid, the formed tubular inflation liner to the formed tubular main liner. Thereafter the heat shrink is removed prior to attaching a balloon about the fused assembly. Optionally, prior to the step of positioning the second opening of the formed tubular inflation liner longitudinally relative to the first opening of the formed tubular main liner, the method may further include applying a braid or coil wound about: (i) the formed tubular main liner, not including the formed tubular inflation liner; (ii) the formed tubular main liner and including the formed tubular inflation liner; or (iii) the formed tubular main liner, wherein a part of the braid is wrapped about the formed tubular inflation liner, while another part of the braid is disposed between the formed tubular main liner and the formed tubular inflation liner.
The foregoing and other features of the present invention will be more readily apparent from the following detailed description and drawings illustrative of the invention wherein like reference numbers refer to similar elements throughout the several views and in which:
The terms “distal” or “proximal” are used in the following description with respect to a position or direction relative to the treating physician or medical interventionalist. “Distal” or “distally” are a position distant from or in a direction away from the physician or interventionalist. “Proximal” or “proximally” or “proximate” are a position near or in a direction toward the physician or medical interventionalist. The terms “occlusion”, “clot” or “blockage” are used interchangeably.
Conventional balloon catheters have a coaxial design wherein a central lumen disposed centrally of the balloon catheter receives a guidewire therethrough while an inflation lumen is disposed coaxially about and completely/fully encircling the central lumen. The present inventive balloon guide catheter is designed so that the inflation lumen partially-encircles or semi-encircles the main lumen, i.e., the inflation lumen does not completely encircle the inflation lumen. Moreover, the center of the inflation lumen may, but need not necessarily, share the same center as that of the main lumen.
When traversing a tortious path through the vessel of the body, the presently arranged inflation lumen provides improved deliverability by providing a shaft that may be connected throughout the shaft, a connectivity that is not provided with completely/fully encircling concentric (coaxial) conventional designs as concentric designs must be substantially unconnected between outer and inner shafts to provide a concentric lumen. Moreover, the conventional concentric (coaxial) design of the inflation lumen about the central lumen takes up a great deal of valuable cross section area between the inner surface and the outer surface of the catheter, that extends in a substantially uniform manner about the circumference of the catheter when compared to the present inventive partially/semi-encircling design which may have varied wall thickness between the inner surface and the outer surface of the catheter, that varies about the circumference of the catheter and allows for a reduced cross sectional area between the inner surface and the outer surface of the catheter. This variation in wall thickness about the circumference of the catheter allows for a larger inner diameter for a given outer diameter when compared to a conventional fully/completely encircling coaxial design because less material is required to define the inflation/deflation lumen for a given lumen cross sectional area. Ideally, the inner diameter of the present inventive partially/semi-encircling design maintains circularity throughout the catheter shaft to accommodate ancillary devices which mostly maintain circularity longitudinally and the outer surface deviates from circularity to slight ovality in order to accommodate the inflation/deflation lumen. The larger inner diameter for a given outer diameter allows the present inventive catheter to receive ancillary devices with larger outer diameters than would be otherwise accommodated with fully/completely encircling concentric designs with the same given outer diameter. Further, the larger inner diameter of the present inventive design will allow for greater aspiration (co-aspiration with an intermediate catheter) flow rates for a given aspiration vacuum pressure. The greater aspiration flow rate serves to enhance flow reversal within the target treatment location and applies a greater suction force to the face of a clot in the vessel aiding in successful retrieval of the clot with aspiration alone or in conjunction with a stent retriever. It is appreciated that the inner and outer surfaces of the present inventive partially/semi-encircling design may both have ovality. Additional embodiments that maintain outer circularity with inner ovality may also be envisaged. Embodiments with inner ovality will be advantageous in a balloon guide catheter when combined with an inner intermediate catheter having circularity because the extra volume provided between the inner oval cross section of the balloon guide catheter and the outer circular cross section of the intermediate catheter provides additional cross section area between the catheters that can be utilized for aspiration flow. Therefore, when accommodating a given intermediate catheter with outer circularity in balloon guide catheters with a given outer diameter, a balloon guide catheter with an inner ovality will allow for greater aspiration flow rates compared to a balloon guide catheter with an inner circularity, especially so for a concentric design as it will also require a greater cross-sectional area for the wall thickness of the catheter to accommodate the inflation/deflation lumen.
Referring to the longitudinal cross-sectional view depicted in
The inflation lumen 110 has one or more exhaust vents defined therein. These exhaust vents may be configured to expunge/purge residual air trapped in the inflation lumen in a radial direction, a longitudinal direction or both. In the example shown in
A microporous membrane 140 covers each of the exhaust vents 135, 135′, wherein the pores of the microporous membrane are sized to permit only the passage of gas (e.g., residual air) therethrough, liquid (inflation medium) dispensed through the inflation lumen is prevented from permeating through the porous membrane allowing the pressure within the inflating lumen to build-up and inflate the balloon as the volume within the balloon fills with the inflation medium. Preferably, the microporous membrane is a certain grade (based on porosity and thickness) of sintered polytetrafluoroethylene (PTFE), for example, sintered polytetrafluoroethylene (ePTFE), that permits the passage of air molecules therethrough but acts as a barrier to larger molecules such as water, saline and contrast medium because of two attributes, (i) hydrophobic membrane and (ii) molar volume. The membrane is hydrophobic in nature and allows the membrane to repel relatively high tension (polar) fluids even with the presence of small pores in a non-pressurized system. Gases on the other hand pass easily through such membranes under very relatively low pressures. For instance, water vapor will pass through the ePTFE microporous membrane, however it is time dependent. With regards to the second factor, the size of the water and contrast medium molecules are greater than the air molecules permitting the air molecule to pass through the membrane containing numerous small pore sizes. In relation to the present invention, the relative sizes of the molecules are the dominant characteristic at play within this application time-frame of injecting fluid through a lumen, where air is expelled through a microporous membrane under relatively high pressure. The micropores of the ePTFE microporous membrane vary in size and are preferably in the size range of approximately 0.02 μm to approximately 500 μm, more preferably in the size range of approximately 5 μm to approximately 100 μm.
The inflation lumen 110 extends axially through the catheter body 100 from proximate its proximal end 145 to its opposite distal tip or end 150. An inflation/inlet vent 130 is defined radially outward through the catheter body 100 and serves as a conduit for the inflation medium between the inflation lumen 110 and a balloon 125 covering the inflation vent 130. Balloon 125 is bonded or adhered to an outer surface of a distal portion of the catheter body 100 forming a seal over the inflation vent 130. In the deflated state shown in
The embodiment shown in
Perspective and longitudinal cross-sectional views of the assembled catheter in accordance with the present invention are depicted in
As shown in
A separately formed inflation liner 410 (e.g., PTFE) is wrapped about its own internal mandrel (e.g., SPC mandrel) forms the inflation lumen 110, as shown in
Referring to
Once the components have been assembled and positioned as desired, an insert is preferably placed to prevent sealing of the opening during heating and thereby maintain fluid communication in the following areas: (i) at the end of the inflation lumen; (ii) between the balloon and the inflation lumen; (iii) as well as between the inflation lumen and the PTFE microporous membrane. Heat is applied whereby the thermoplastic materials reflow to form a secure assembly while the insert prohibits sealing of the communication channels. Lastly, the insert is removed and the balloon 125 is assembled (e.g., heat welded) to the secure assembly. In the configuration in
The location of the inflation/exhaust vents encourages full venting of the residual air and only when the residual air has been fully bled, will the balloon inflate with the inflation medium initially used to bleed the catheter of residual air. To facilitate this, the inflation port size and exhaust vent size is preferably optimized so that the pressure required to inflate the balloon is greater than the pressure required to vent residual air.
In
The present inventive balloon guide catheter with positive venting is prepped by a physician or interventionalist prior to introduction into the body. Specifically, a syringe 120 containing an inflation medium is connected to the inflation lumen 110 via the inflation port 115. As the physician or interventionalist dispenses the inflation medium into the inflation lumen 110 using the syringe 120 the residual air therein is pushed by the inflation medium through the inflation lumen 110 in a distal direction. Since the residual air is positively pushed through the inflation lumen by the inflation medium the need for a vacuum or negative pressure to purge the residual air from the catheter is eliminated. In greater detail, initially, when the balloon is deflated and tightly wrapped in physical contact against the outer surface of the catheter body, the residual air follows the route or path of least resistance passing through the microporous membrane 140 and exiting from the catheter body through the exhaust openings 135, 135′. As the inflation medium is introduced into the inflation port, only the residual gas (e.g., air) permeates through the microporous membranes 140 and outward through the respective radially and longitudinally configured exhaust openings 135, 135′. Since the microporous membranes 140 prohibit the liquid inflation medium from permeating therethrough, initially due to the fact that the residual gas (e.g., air) previously trapped inside the catheter passes through the porous membranes and outward from the exhaust openings 135, 135′ the pressure in the inflation lumen 110 remains somewhat equalized or constant. However, once the residual gas (e.g., air) in the catheter has been bled, continued dispensing of the pressurized inflation medium into the inflation lumen causes a build-up of pressure at the inflation opening 130 exerting a radially outward force on the balloon 125 causing it to expand radially outward as it fills with the inflation medium.
Only one inflation opening 130 is shown in
An alternative configuration of the main/central lumen 305 and partially/semi-encircling inflation lumen 310 of the present inventive balloon guide catheter is shown in
In yet a further modification of the configuration of the balloon catheter in accordance with the present invention, the assembled catheter body at its distal end may be configured to have an expandable distal end or tip 450 as depicted in
Prior to dispensing the inflation medium into the inflation lumen 410, the balloon 425 is in a deflated state and the expandable distal end or tip 450 of the catheter is in a radially compressed state, as seen in
Referring to
A restrictive band 495 may be disposed about the balloon proximally of the expandable distal end or tip 450 (
Yet another alternative configuration of the expandable distal tip or end of the catheter is illustrated in
A last configuration of the expandable distal end or tip of the catheter is depicted in
In each of the inventive embodiments described herein, since residual air is exhausted distally from the catheter, the present inventive balloon catheter is to be prepped by purging the device prior to being introduced into the body. Failure to purge the catheter prior to introduction into the body will result in the exhausted residual air undesirably entering the vascular system potentially causing harm to the patient. The positive venting system associated with the present inventive balloon guide catheters simplifies the prepping steps for purging residual air from the device thereby minimizing barriers to use of the device by physicians or interventionalists.
Thus, while there have been shown, described, and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions, substitutions, and changes in the form and details of the systems/devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of those elements and/or steps that perform substantially the same function, in substantially the same way, to achieve the same results be within the scope of the invention. Substitutions of elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale, but that they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.
Every issued patent, pending patent application, publication, journal article, book or any other reference cited herein is each incorporated by reference in their entirety.
This application claims the benefit of the following: U.S. Provisional Application No. 62/845,683, filed on May 9, 2019; U.S. Provisional Application No. 62/845,699, filed on May 9, 2019; U.S. Provisional Application No. 62/845,711, filed on May 9, 2019; and U.S. Provisional Application No. 62/845,747, filed on May 9, 2019, each of which is herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4323071 | Simpson | Apr 1982 | A |
4684363 | Ari et al. | Aug 1987 | A |
4715378 | Pope, Jr. et al. | Dec 1987 | A |
4753238 | Gaiser | Jun 1988 | A |
4793351 | Landman et al. | Dec 1988 | A |
4811737 | Rydell | Mar 1989 | A |
4821722 | Miller et al. | Apr 1989 | A |
5035705 | Burns | Jul 1991 | A |
5100385 | Bromander | Mar 1992 | A |
5135486 | Eberle | Aug 1992 | A |
5176698 | Burns | Jan 1993 | A |
5224933 | Bromander | Jul 1993 | A |
5256143 | Miller | Oct 1993 | A |
5800421 | Lemelson | Sep 1998 | A |
6102891 | Maria van Erp | Aug 2000 | A |
6102931 | Thornton | Aug 2000 | A |
6709429 | Schaefer et al. | Mar 2004 | B1 |
6811559 | Thornton | Nov 2004 | B2 |
6953431 | Barthel | Oct 2005 | B2 |
6994687 | Shkolnik | Feb 2006 | B1 |
7160266 | Shkolnik | Jan 2007 | B2 |
7338511 | Mirigian et al. | Mar 2008 | B2 |
7678075 | Wantink et al. | Mar 2010 | B2 |
8298218 | Mahrouche | Oct 2012 | B2 |
8926560 | Dinh et al. | Jan 2015 | B2 |
9155869 | Ehrenreich et al. | Oct 2015 | B2 |
9463035 | Greenhalgh et al. | Oct 2016 | B1 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9833252 | Sepetka et al. | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
10576254 | Yang et al. | Mar 2020 | B2 |
10682152 | Vale et al. | Jun 2020 | B2 |
11202891 | Gulachenski et al. | Dec 2021 | B2 |
20020103473 | Roychowdhury | Aug 2002 | A1 |
20030023204 | Vo et al. | Jan 2003 | A1 |
20040260329 | Gribbons et al. | Dec 2004 | A1 |
20050070881 | Gribbons | Mar 2005 | A1 |
20050124932 | Foster et al. | Jun 2005 | A1 |
20050182359 | Chin | Aug 2005 | A1 |
20060030814 | Valencia et al. | Feb 2006 | A1 |
20080200904 | Cluff et al. | Aug 2008 | A1 |
20100234940 | Dolan | Sep 2010 | A1 |
20120265134 | Echarri et al. | Oct 2012 | A1 |
20120296366 | Rundquist et al. | Nov 2012 | A1 |
20130289549 | Nash et al. | Oct 2013 | A1 |
20140188043 | Shibahara | Jul 2014 | A1 |
20140257359 | Tegels et al. | Sep 2014 | A1 |
20150032049 | Hopkinson et al. | Jan 2015 | A1 |
20150073467 | Eaton | Mar 2015 | A1 |
20150174363 | Sutermeister et al. | Jun 2015 | A1 |
20150224290 | Chanduszko et al. | Aug 2015 | A1 |
20160001040 | Yamaguchi et al. | Jan 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Grandfield | Apr 2017 | A1 |
20170100183 | Iaizzo et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon | Dec 2017 | A1 |
20180333192 | Sliwa et al. | Nov 2018 | A1 |
20190167287 | Vale et al. | Jun 2019 | A1 |
20190359786 | Trahan et al. | Nov 2019 | A1 |
20200179657 | Liu | Jun 2020 | A1 |
20200246036 | Kallmes et al. | Aug 2020 | A1 |
20220143360 | Kugler et al. | May 2022 | A1 |
Number | Date | Country |
---|---|---|
2016168151 | Sep 2016 | JP |
2007139799 | Dec 2007 | WO |
2013163254 | Oct 2013 | WO |
2017192999 | Nov 2017 | WO |
Entry |
---|
Co-Pending, co-owned, U.S. Appl. No. 16/601,185, filed Oct. 14, 2019. |
Co-Pending, co-owned, U.S. Appl. No. 16/601,221, filed Oct. 14, 2019. |
Co-Pending, co-owned, U.S. Appl. No. 16/601,202, filed Oct. 14, 2019. |
L.E. Romans, “The Use of Contrast Media in the CT Department”, CEWebsource.com, May 15, 2013 (50 pp). |
Number | Date | Country | |
---|---|---|---|
20200353228 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
62845683 | May 2019 | US | |
62845711 | May 2019 | US | |
62845747 | May 2019 | US | |
62845699 | May 2019 | US |